Literature DB >> 1568211

Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q.

T Yamaguchi1, J Toguchida, T Yamamuro, Y Kotoura, N Takada, N Kawaguchi, Y Kaneko, Y Nakamura, M S Sasaki, K Ishizaki.   

Abstract

We have investigated the involvement of tumor suppressor genes in the genesis of osteosarcoma by analyzing allele losses at polymorphic loci in tumor tissues. Genotypes of DNA from primary osteosarcoma tissue and corresponding normal cells from 37 patients were analyzed at 58 polymorphic loci representing each autosomal chromosome arm except 5p and 20q. Allele losses were found at polymorphic loci on 36 of 37 chromosome arms analyzed. In particular, four of them showed frequencies of allele loss higher than 60%: 3q (75%); 13q (68%); 17p (72%); and 18q (64%). This result suggests that, in addition to the RB (retinoblastoma) gene on 13q and the p53 gene on 17p, at least two more tumor suppressor genes located on 3q and 18q are frequently involved in the development of osteosarcoma. The extent of allele losses as defined by fractional allelic loss among 36 tumors was diverse, from 0 to 0.64. The median fractional allelic loss value of 0.32 was much higher than those previously reported in colorectal carcinoma and breast carcinoma. Although no definite association of fractional allelic loss value to clinical prognosis of each case was found in osteosarcoma, tumors with 17p loss were more prone to the early onset of lung metastasis than tumors without 17p loss, indicating that allele loss on chromosome 17p can be a useful measure of prognosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1568211

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma.

Authors:  Rex C Haydon; Andrea Deyrup; Akira Ishikawa; Robert Heck; Wei Jiang; Lan Zhou; Tao Feng; David King; Hongwei Cheng; Benjamin Breyer; Terrance Peabody; Michael A Simon; Anthony G Montag; Tong-Chuan He
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

2.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 3.  Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.

Authors:  Ying-Wen Su; Ming-Chih Chang; Ming-Fu Chiang; Ruey-Kuen Hsieh
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

4.  Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays.

Authors:  R Mei; P C Galipeau; C Prass; A Berno; G Ghandour; N Patil; R K Wolff; M S Chee; B J Reid; D J Lockhart
Journal:  Genome Res       Date:  2000-08       Impact factor: 9.043

Review 5.  Loss of heterozygosity analyzed by single nucleotide polymorphism array in cancer.

Authors:  Hai-Tao Zheng; Zhi-Hai Peng; Sheng Li; Lin He
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

Review 6.  Osteosarcoma development and stem cell differentiation.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Rex C Haydon; Tong-Chuan He
Journal:  Clin Orthop Relat Res       Date:  2008-06-18       Impact factor: 4.176

7.  Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16.

Authors:  W F Dietrich; E H Radany; J S Smith; J M Bishop; D Hanahan; E S Lander
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

8.  Hereditary multiple exostosis and chondrosarcoma: linkage to chromosome II and loss of heterozygosity for EXT-linked markers on chromosomes II and 8.

Authors:  J T Hecht; D Hogue; L C Strong; M F Hansen; S H Blanton; M Wagner
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

9.  Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone.

Authors:  Y Ueda; B Dockhorn-Dworniczak; S Blasius; W Mellin; P Wuisman; W Böcker; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Microsatellite instability in sarcomas.

Authors:  S S Martin; W G Hurt; L K Hedges; M G Butler; H S Schwartz
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.